48,874
edits
Difference between revisions of "Low-grade oncocytic renal tumour"
Jump to navigation
Jump to search
Low-grade oncocytic renal tumour (view source)
Revision as of 04:07, 20 March 2024
, 04:07, 20 March 2024no edit summary
| Line 10: | Line 10: | ||
| IHC = CK7 +ve, CD117 -ve, GATA3 +ve, [[PAX8]] +ve | | IHC = CK7 +ve, CD117 -ve, GATA3 +ve, [[PAX8]] +ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = TSC/mTOR pathway mutation | ||
| IF = | | IF = | ||
| Gross = | | Gross = | ||
| Line 80: | Line 80: | ||
==Molecular== | ==Molecular== | ||
*[[Renal neoplasms with TSC/mTOR mutations|TSC/mTOR pathway mutation]].<ref name=pmid35203531>{{cite journal |authors=Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O |title=TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background |journal=Biomedicines |volume=10 |issue=2 |pages= |date=January 2022 |pmid=35203531 |pmc=8869370 |doi=10.3390/biomedicines10020322 |url=}}</ref> | *[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid35203531>{{cite journal |authors=Pivovarcikova K, Alaghehbandan R, Vanecek T, Ohashi R, Pitra T, Hes O |title=TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background |journal=Biomedicines |volume=10 |issue=2 |pages= |date=January 2022 |pmid=35203531 |pmc=8869370 |doi=10.3390/biomedicines10020322 |url=}}</ref> | ||
==Sign out== | ==Sign out== | ||